Literature DB >> 3941280

Anti-HBs responses to vaccination with a human hepatitis B vaccine made by recombinant DNA technology in yeast.

F B Hollinger, C L Troisi, P E Pepe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3941280     DOI： 10.1093/infdis/153.1.156

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Four-year experience with a recombinant hepatitis B vaccine.

Authors:  W Jilg; M Schmidt; F Deinhardt
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

2.  Genetically engineered hepatitis B vaccine now available.

Authors: 
Journal:  CMAJ       Date:  1987-08-15       Impact factor: 8.262

3.  Simultaneous administration of hepatitis B vaccine with other E.P.I. vaccines.

Authors:  S K Mittal; S Rao; S Kumari; V Aggarwal; C Prakash; S Thirupuram
Journal:  Indian J Pediatr       Date:  1994 Mar-Apr       Impact factor: 1.967

4.  Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults.

Authors:  P Dentico; R Buongiorno; A Volpe; A Zavoianni; G Pastore; O Schiraldi
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

5.  Infectious diseases and the anaesthetist.

Authors:  R A Browne; M A Chernesky
Journal:  Can J Anaesth       Date:  1988-11       Impact factor: 5.063
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.